These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6535745

  • 1. Dexamethasone suppression test in autistic children.
    Hoshino Y, Ohno Y, Murata S, Yokoyama F, Kaneko M, Kumashiro H.
    Folia Psychiatr Neurol Jpn; 1984; 38(4):445-9. PubMed ID: 6535745
    [Abstract] [Full Text] [Related]

  • 2. Hypothalamic-pituitary-adrenal axis function in children with attention-deficit hyperactivity disorder.
    Kaneko M, Hoshino Y, Hashimoto S, Okano T, Kumashiro H.
    J Autism Dev Disord; 1993 Mar; 23(1):59-65. PubMed ID: 8463202
    [Abstract] [Full Text] [Related]

  • 3. The diurnal variation and response to dexamethasone suppression test of saliva cortisol level in autistic children.
    Hoshino Y, Yokoyama F, Watanabe M, Murata S, Kaneko M, Kumashiro H.
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):227-35. PubMed ID: 3437610
    [Abstract] [Full Text] [Related]

  • 4. Hypothalamic-pituitary-adrenal axis function in patients with chronic depression.
    Watson S, Gallagher P, Del-Estal D, Hearn A, Ferrier IN, Young AH.
    Psychol Med; 2002 Aug; 32(6):1021-8. PubMed ID: 12214783
    [Abstract] [Full Text] [Related]

  • 5. Disregulation of hypothalamic-pituitary-adrenal axis in the mentally retarded.
    Sandman CA, Barron JL, Parker L.
    Pharmacol Biochem Behav; 1985 Jul; 23(1):21-6. PubMed ID: 4034619
    [Abstract] [Full Text] [Related]

  • 6. The metyrapone test in schizophrenic patients and healthy subjects.
    Morphy MA, Fava GA, Carson SW, Perini GI, Molnar G, Jusko WJ.
    Neuropsychobiology; 1985 Jul; 14(1):35-8. PubMed ID: 4069347
    [Abstract] [Full Text] [Related]

  • 7. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients.
    Mück-Seler D, Pivac N, Jakovljević M, Brzović Z.
    Biol Psychiatry; 1999 Jun 01; 45(11):1433-9. PubMed ID: 10356625
    [Abstract] [Full Text] [Related]

  • 8. Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features.
    Kaneko M, Yokoyama F, Hoshino Y, Takahagi K, Murata S, Watanabe M, Kumashiro H.
    Neuropsychobiology; 1992 Jun 01; 25(1):1-7. PubMed ID: 1351264
    [Abstract] [Full Text] [Related]

  • 9. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
    Jakovljević M, Mück-Seler D, Pivac N, Crncević Z.
    Neuropsychobiology; 1998 Jun 01; 37(3):142-5. PubMed ID: 9597670
    [Abstract] [Full Text] [Related]

  • 10. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
    Rybakowski J, Linka M, Matkowski K, Kanarkowski R.
    Psychiatr Pol; 1991 Jun 01; 25(5):9-15. PubMed ID: 1821997
    [Abstract] [Full Text] [Related]

  • 11. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF, Prudic J, Rothpearl A, Nurnberg HG.
    J Affect Disord; 1985 Sep 01; 9(2):107-13. PubMed ID: 2932482
    [Abstract] [Full Text] [Related]

  • 12. Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism.
    Tordjman S, Anderson GM, McBride PA, Hertzig ME, Snow ME, Hall LM, Thompson SM, Ferrari P, Cohen DJ.
    J Child Psychol Psychiatry; 1997 Sep 01; 38(6):705-15. PubMed ID: 9315980
    [Abstract] [Full Text] [Related]

  • 13. Lower cortisol and higher ACTH levels in individuals with autism.
    Curin JM, Terzić J, Petković ZB, Zekan L, Terzić IM, Susnjara IM.
    J Autism Dev Disord; 2003 Aug 01; 33(4):443-8. PubMed ID: 12959423
    [Abstract] [Full Text] [Related]

  • 14. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA, Fava GA, Perini GI, Molnar G, Zielezny M, Lisansky J.
    Psychiatry Res; 1985 Jun 01; 15(2):153-8. PubMed ID: 3862146
    [Abstract] [Full Text] [Related]

  • 15. Dexamethasone suppression test in schizophrenic patients: report from India.
    Joseph S, Kulhara P, Dash RJ.
    Biol Psychiatry; 1987 Jun 01; 22(6):792-5. PubMed ID: 3593821
    [No Abstract] [Full Text] [Related]

  • 16. Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels.
    Holsboer-Trachsler E, Buol C, Wiedemann K, Holsboer F.
    Acta Psychiatr Scand; 1987 Jun 01; 75(6):608-13. PubMed ID: 3618283
    [Abstract] [Full Text] [Related]

  • 17. Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
    Zis AP, Haskett RF, Albala AA, Carroll BJ, Lohr NE.
    Arch Gen Psychiatry; 1985 Apr 01; 42(4):383-6. PubMed ID: 3977556
    [Abstract] [Full Text] [Related]

  • 18. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms.
    Pivac N, Mück-Seler D, Jakovljević M.
    Neuropsychobiology; 1997 Apr 01; 36(1):19-21. PubMed ID: 9211439
    [Abstract] [Full Text] [Related]

  • 19. HPA axis dysregulation in men with hypersexual disorder.
    Chatzittofis A, Arver S, Öberg K, Hallberg J, Nordström P, Jokinen J.
    Psychoneuroendocrinology; 2016 Jan 01; 63():247-53. PubMed ID: 26519779
    [Abstract] [Full Text] [Related]

  • 20. The metyrapone test in affective disorders and schizophrenia.
    Fava GA, Carson SW, Perini GI, Morphy MA, Molnar G, Jusko WJ.
    J Affect Disord; 1984 Jun 01; 6(3-4):241-7. PubMed ID: 6235255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.